Science Current Events | Science News | Brightsurf.com
 

Survival Current Events | Survival News | 3

Sort By: Page Views | Date

High-flux hemodialysis prolongs survival in many patients with CKD
High-flux hemodialysis (which removes large toxins) reduces the risk of premature death in many patients with chronic kidney disease (CKD), according to a study appearing in the March 2009 issue of the Journal of the American Society Nephrology (JASN).   view more (2009-02-23)

Analysis confirms benefits of combining trastuzumab and chemotherapy
A recent meta-analysis of five major breast cancer trials has confirmed that combination treatment with the antibody trastuzumab and chemotherapy improves survival in women with operable HER-2 positive breast cancer.   view more (2007-07-09)

Barrett's esophagus patients have same survival rates as general population
New Mayo Clinic research has found that survival rates of patients with Barrett's esophagus, which can be a precursor for esophageal cancer, are no different than the survival rates for the general population.   view more (2009-10-27)

OHSU Cancer Institute researchers get closer to predict survivability for some cancer patients
Oregon Health & Science University Cancer Institute researchers have developed a Web-based software program that can help head and neck cancer patients better predict their survivability.   view more (2007-06-28)

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene
Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.   view more (2008-01-02)

Innovative device to treat brain cancer shows promise in early studies
New early data showed that an investigational device that specifically targets rapidly growing cancer cells with intermediate frequency electrical fields -- called Tumor-Treating Fields (TTFields) -- more than doubled the median overall survival rates in patients with recurrent glioblastoma multiforme (GBM), the most common and aggressive type of... view more... (2007-05-30)

Complete response with oblimersen combination improves survival of CLL patients
Relapsed chronic lymphocytic leukemia (CLL) patients who had a complete response to combination therapy that included the drug oblimersen survived significantly longer than patients treated with chemotherapy alone, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American... view more... (2007-12-10)

Type-1 Diabetics Benefit from Simultaneous Pancreas and Kidney Transplants
Pancreas transplants have been slow to gain acceptance as treatment for type-1 insulin-dependent diabetic patients suffering end-stage renal disease. A recent study, to be published in the September 2003 issue of the British Journal of Surgery, however, concludes that simultaneous pancreas and kidney transplant (SPK) is the treatment of choice for... view more... (2003-08-21)

Age is more than a number — In barn owls, it reveals how susceptible one is to climate change
Fluctuations in weather and the environment affect survival and reproduction of animals. But are all individuals within a population equally susceptible? Theory on the evolution in age-structured populations suggests not - those life stages that are more important for overall fitness should be less susceptible to environmental variation than other... view more... (2007-01-11)

Intense chemotherapy wards off recurrence in half of mantle cell lymphoma patients after seven years
More than half of younger mantle cell lymphoma patients who received an intensive regimen of chemotherapy as frontline treatment remain in remission seven years later, researchers at The University of Texas M. D. Anderson Cancer Center report today at the 50th annual meeting of the American Society of Hematology.   view more (2008-12-10)

Chemotherapy-induced anemia increases risk of local breast cancer recurrence
Patients with breast cancer who developed anemia during chemotherapy had nearly three times the risk of local recurrence as those who did not, according to a study published in the April 1 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research.   view more (2008-04-01)

Advances in liver surgery enable the prospect of curative treatment for more patients
Although many prognostic factors predicting survival and cancer recurrence in patients undergoing surgery for colorectal liver metastases are already identified, the effects of newly introduced technologies and new drugs in the treatment of these patients are still poorly studied because of the presence of many involved factors.   view more (2009-06-15)

The cost of improving dialysis care
Improving survival among dialysis patients may increase treatment costs significantly, according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA.   view more (2009-11-02)

Analysis shows that vidaza prolongs survival in patients with higher-risk myelodysplastic syndromes
The Myelodysplastic Syndromes (MDS) Foundation announced today that a subanalysis of the AZA-001 phase III international clinical trial shows that treatment with VIDAZA (azacitidine) can extend overall survival and reduce the risk of death in elderly higher-risk MDS patients.   view more (2008-12-11)

Kidney transplant survival can be long-term for people with HIV
A Johns Hopkins study finds that HIV-positive kidney transplant recipients could have the same one-year survival rates for themselves and their donor organs as those without HIV, provided certain risk factors for transplant failure are recognized and tightly managed.   view more (2009-01-20)

Experience affects new neuron survival in adult brain; study sheds light on learning, memory
Experience in the early development of new neurons in specific brain regions affects their survival and activity in the adult brain, new research shows. How these new neurons store information about these experiences may explain how they can affect learning and memory in adults.   view more (2007-03-23)

Combination Chemotherapy Best Option For Treating Relapsed Ovarian Cancer (p 2099)
Results of a European study in this week's issue of THE LANCET suggest that combination treatment with paclitaxel and platinum-based chemotherapy could result in a modest but important survival benefit for women with relapsing ovarian cancer compared with women treated with platinum-based chemotherapy alone. Ovarian cancer is the fourth most... view more... (2003-06-19)

News from Cancer: Disparities in head and neck cancer patients
A new analysis finds considerable disparities in survival related to race and socio-economic status among patients with head and neck cancer.   view more (2008-10-06)

No need to change post-operative treatment for lung cancer, says clinical scientist
Embargoed: 09.00 hrs CET Tuesday 23 September 2003   view more (2003-09-21)

Therapy For Mice With Prion Disease Could Offer Benefit To Human Beings With CJD
Authors of a fast-track research letter in this week's issue of THE LANCET describe a therapeutic treatment which increased the survival time for mice with prion disease. These results could represent a new approach to treating CJD in human beings. The lack of an immune response to prions-the infectious proteins that cause scrapie, bovine... view more... (2002-07-17)
Sort By: Page Views | Date
© 2009 BrightSurf.com